Introduction
Adipose tissue is primarily composed of adipocytes which are an important site of energy storage and endocrine activity.
Adipocyte dysfunction leads to a reduction in the level of the insulin-sensitizing factor, adiponectin, 1 and to an increase in cytokines that promote insulin resistance, inflammation and atherosclerosis, such as tumour necrosis factor-α, plasminogen a Y Gong and J Li contributed equally to this article. OBJECTIVE: To explore the adipose tissue endocrine mechanism of pioglitazone and its possible prophylactic role in insulin resistance. METHODS: Male Wistar rats were randomized to receive a normal diet (N group), a high-fat insulin resistanceinducing diet (IR group), or a high-fat diet plus treatment with pioglitazone (P group). Glucose tolerance and insulin resistance were tested at weeks 10 and 11 after starting the diet and, at week 12, adipose, liver and skeletal muscle tissue samples were taken. HepG2 cells were cultured with palmitic acid (PA), pioglitazone and PA plus pioglitazone, and RNA interference was used to downregulate adiponectin receptor (AdipoR) 2 in these cells. The mRNA and protein levels of adipokines (resistin and adiponectin), AdipoR1 and 2 and uptake of [ 3 H]-labelled glucose were measured in the HepG2 cells. RESULTS: Resistin and adiponectin in adipose tissue and AdipoR2 in liver tissue were significantly decreased in the IR group compared with the N group. Adiponectin and AdipoR2 were significantly increased and insulin resistance significantly decreased in the P group versus the IR group. In HepG2 cells, AdipoR2 levels and glucose uptake decreased significantly when PA was ≥ 200 µM, but were elevated by pioglitazone. Small interfering RNA-AdipoR2 confirmed glucose uptake in liver was regulated by AdipoR2. CONCLUSIONS: Pioglitazone prevented insulin resistance in rats fed a high-fat diet. Liver AdipoR2-mediated glucose uptake is important in the prophylactic effect of pioglitazone on insulin resistance. activator inhibitor-1 and interleukins. 2 Adiponectin is the only adipokine (a cytokine secreted from adipose tissue) that is negatively correlated with body fat. 3 Plasma levels of adiponectin are decreased in individuals with impaired glucose tolerance and even further in type 2 diabetes mellitus compared with people with normal glucose tolerance, and are closely related to obesity and insulin resistance. 4 Two adiponectin receptor (AdipoR) subtypes, AdipoR1 and AdipoR2, have been identified. 5 When adiponectin binds with AdipoRs, the activities of peroxisome proliferatoractivated receptor (PPAR)-α, (PPAR)-γ, 5'-AMP-activated protein kinase and p38 mitogen-activated protein kinase are regulated. 5 -7 The exact mechanism by which adiponectin reduces insulin resistance is not known.
Another important adipokine is resistin, originally believed to be the controlling factor in obesity and diabetes; 1 however subsequent research has shown contradictory results. Some studies have shown that resistin levels do not decrease in obese mice or in the insulin-resistant rat, while other studies have reported that the antidiabetes drug metformin increases resistin levels in a rat model of obesity, diabetes and dyslipidaemia. 4, 8, 9 Further studies are needed to determine the exact role of resistin in insulin resistance. Thiazolidinediones (TZDs) are powerful selective agonists of PPAR-γ that improve insulin sensitivity by activating the transcription of specific genes. TZDs include pioglitazone and rosiglitazone; 10 the latter has not been available in Europe since 2010 because of its association with a high risk of congestive heart failure. 11 It is generally accepted that pioglitazone ameliorates oxidative stress, reduces lipogenesis and cirrhosis in the liver, 12 -14 decreases the triglyceride level and oxidative stress, and promotes synthesis of glycogen in skeletal muscle. 15, 16 Furthermore, pioglitazone may increase the proportion of functional small cells in adipose tissue and improve adipose tissue distribution. 17 -19 The present study aimed to evaluate the possible prophylactic effect of pioglitazone in preventing the development of insulin resistance in rats fed a high-fat diet and used the human hepatoma HepG2 cell line to elucidate its effect on adipose endocrine function.
Materials and methods

ANIMAL CARE
Forty-five male specific-pathogen-free (SPF) Wistar albino rats, aged 5 -6 weeks and weighing (mean ± SD) 160 ± 10 g, were purchased from the Institute of Laboratory Animal Sciences in the Chinese Academy of Medical Sciences (Beijing, China). The rats were group housed five per cage and kept under conditions of constant temperature (mean ± SD 23 ± 1°C) and humidity (mean ± SD 50 ± 5%) in a standard 12-h light/12-h dark cycle with free access to food and water. Food was supplied every day before dark after cleaning and the residual food for each group was weighed.
Animal 
STUDY TREATMENTS
The 45 rats were randomly divided into three groups using computer generated random numbers (n = 15 per group): the normal (N) Y Gong, J Li, C Li et al.
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group was fed a normal diet (359.4 kcal/100 g; 13.5% from fat, 21.1% from protein, 65.4% from carbohydrate); the insulinresistant (IR) group was fed a high-fat diet (474.2 kcal/100 g; 58.8% from fat, 15.2% from protein, 26.0% from carbohydrate); and the pioglitazone-treated (P) group was fed the high-fat diet and also given 10 mg/kg body weight per day pioglitazone (Yamanouchi Pharmaceuticals, Tokyo, Japan) orally by gastric tube before the food. The rats were maintained on these diets until they were sacrificed at week 12.
SAMPLE COLLECTION
Blood glucose, insulin and free fatty acid (FFA) levels were measured at baseline, as described below, using blood taken from the tail vein of the rats. Glucose tolerance and insulin resistance tests (as described below) were carried out twice in all animals, once in week 10 and once in week 11 after commencement of the above-mentioned diets and when a significant difference in glucose tolerance was observed between the normal and high-fat diet groups. The animals were sacrificed by heavy anaesthesia after overnight fasting (8 -12 h) . After sacrifice, blood samples (4 ml) were obtained from the right ventricle without the use of anticoagulant for the immediate measurement of blood glucose levels; serum samples were prepared by centrifuging at 2000 g (4°C for 15 min) and they were stored at −20°C for subsequent measurement of insulin and FFA levels as described below.
Tissue samples were taken from rat liver, skeletal muscle, adipose tissue, heart, kidney and testis from all rats following sacrifice at week 12. The tissues were dissected and washed promptly with normal saline. Skeletal muscle was isolated from the quadriceps.
The epididymal and retroperitoneal fat pads were weighed after dissection. All tissue samples were then quick frozen in liquid nitrogen and stored at −80°C for reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analyses as described below.
MEASUREMENT OF BLOOD GLUCOSE, INSULIN AND FFA LEVELS
After sacrifice at 12 weeks, blood glucose was tested using a standard glucometer (Accu-Chek ® , Roche Diagnostics, Mannheim, Germany) using a drop of right ventricle blood from each rat. Serum insulin levels were measured by radioimmunoassay (RIA) using a Sensitive Rat Insulin RIA kit (SRI-13K; Millipore, Billerica, MA, USA) according to the manufacturer's instructions. The homeostasis model assessment for insulin resistance (HOMA-IR) was determined from the fasting blood glucose (FBG) and fasting insulin (FINS) tests of right ventricle blood for each group: HOMA-IR) = log e [(FBG × FINS) / 22.5].
Serum FFA levels were determined spectrophotometrically by an acyl-coenzyme A oxidase-based colorimetric kit (NEFA Ctest; Wako Pure Chemical Industries, Osaka, Japan) using a LabSpect 003 analyser (Hitachi Medical Corp., Kashiwa, Japan).
GLUCOSE TOLERANCE AND INSULIN RESISTANCE TESTS
As described above, glucose tolerance and insulin resistance tests were carried out once in week 10 and once in week 11 in all animals. In each case the insulin resistance test was carried out 3 days after the glucose tolerance test. Rats were fasted for 5 -7 h in the morning after being fed overnight ad libitum. They were then anaesthetized with 40 mg/kg body weight pentobarbital intraperitoneally. To test glucose tolerance and insulin resistance the mice were injected with 2 g/kg body weight glucose Y Gong, J Li, C Li et al.
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intragastrically and 0.4 IU/kg body weight insulin subcutaneously, respectively. Blood samples were taken from the tail vein of each rat at 0, 30, 60 and 120 min after glucose or insulin administration and assessed directly for blood glucose levels as described above. Glucose tolerance and insulin resistance were assessed by comparing glucose levels at each time point and the area under the curve (AUC) was calculated using the following equation:
CULTURE OF HEPG2 CELLS WITH PIOGLITAZONE AND PA
Human hepatoma HepG2 cells were purchased from the cell bank of Peking Union Medical College Hospital (Beijing, China) to study the effects of pioglitazone on AdipoRs levels and glucose uptake. The cells were grown for 2 -3 days, at 37°C in 5% carbon dioxide and 95% relative humidity, in high-glucose Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% glutaminepenicillin-streptomycin (all from Hyclone Laboratories, Logan, UT, USA) to attain 80% confluence.
Pioglitazone stock culture solutions were prepared in advance by dissolving 1 g pioglitazone in 5 ml dimethylsulphoxide (Sigma-Aldrich, St Louis, MO, USA) and diluting into 50 ml of DMEM to give final concentrations of 100, 200 and 400 µM. These stock solutions had a guarantee period of up to 2 weeks when stored at 4°C. Palmitic acid (PA; Sigma-Aldrich) was prepared immediately before use by adding 13.9 mg PA to 0.5 ml of 0.1 M sodium hydroxide, heating at 100°C for 1 h and then adding into high glucose DMEM that had been preheated to 45°C to give the final protocol concentration of 10 µM.
The cells were divided into eight groups cultured in triplicate in 9-cm dishes: control group; pioglitazone-treated group (10 µM); three groups treated with PA at concentrations of 100, 200 and 400 µM, and three matched groups treated with PA at concentrations of 100, 200 and 400 µM each combined with 10 µM pioglitazone (PA + P). After treatment for 24 h, the culture medium was removed and the cell monolayer was washed with 0.01 M phosphate-buffered saline (PBS), pH 7.4, and collected for measurement of mRNA and cell protein.
ASSESSMENT OF CELL SURVIVAL
Cell survival was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Briefly, MTT was dissolved in 0.01 M PBS, pH 7.4, at a concentration of 5 mg/ml and sterilized by passage through a 0.22 Millipore™ membrane filter (Millipore). The HepG2 cells were plated in 96-well plates at a density of 2 × 10 4 cells/ml and then treated with PA and pioglitazone, as described above, for 24, 48, 72 and 96 h. The stock MTT solution was added (1 part to 10 parts medium) to each well and the plate was then incubated at 37°C for 4 h. Acid isopropanol (40 µl of 10 M hydrochloric acid in 100 µl isopropanol; Beijing Chemical Co. Ltd, Beijing, China) was added to each well and mixed thoroughly to ensure that all the crystals were dissolved. The absorbance was read on a µQuant microplate reader (BioTek Instruments, Winooski, VT, USA) at a wavelength of 595 nm.
RNA INTERFERENCE DOWNREGULATION OF ADIPOR2
To downregulate AdipoR2 in the HepG2 cells, RNA interference was used. The SMARTpool™ small interfering RNA (siRNA) Y Gong, J Li, C Li et al.
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for AdipoR2 and DharmaFECT transfection reagents were purchased from Dharmacon (Thermo Scientific, Lafayette, CO, USA). For gene knockdown experiments, cells were plated in 6-cm dishes and cultured for 48 h at 37°C in a 5% carbon dioxide atmosphere in α-Minimum Essential Medium (MEM) containing 10% FBS and 1% glutaminepenicillin-streptomycin until they reached 30 -40% confluency. The cells were then cultured in antibiotic-free α-MEM at 37°C for a further 24 h and then plated (100 µl/well) in a 96-well plate at 0.5 × 10 4 cells/well for culture overnight to reach 1 × 10 4 cells/well. The cells were transfected overnight with siRNAs (25 nM) using the DharmaFECT transfection reagents at a density of 1 × 10 4 cells/well, according to the manufacturer's instructions. The medium was then removed and the cells were cultured in α-MEM with 10% FBS and 1% glutamine-penicillinstreptomycin for an additional 24 -48 h at 37°C in a 5% carbon dioxide atmosphere. 6 
2-DEOXY-[ 3 H]-D-GLUCOSE UPTAKE ASSAY
The HepG2 cells and HepG2 cells transfected with AdipoR2 siRNA were cultured in 24-well plates until they were confluent and were then cultured for 24 h under the experimental conditions described above. The cells were washed three times in Krebs-Ringer phosphate (KRP) buffer (130 mM saline, 5 mM potassium chloride, 1.3 mM calcium chloride, 1.3 mM magnesium sulphate, 10 mM disodium hydrogen phosphate, pH 7. 4) and stimulated with 50 mU/l bovine insulin (Sigma-Aldrich, St Louis, MO, USA) in KRP buffer for 30 min at 37°C. Then, 2-deoxy-[ 3 H]-D-glucose (3.7 × 10 4 Bq/l; Institute of High Energy Physics Chinese Academy of Sciences, Beijing, China) was added to each well for 15 min. The cells were washed three times in ice-cold 0.01 M PBS, pH 7.4, and solubilized in 0.1 M sodium hydroxide. Protein levels were determined with a bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific, Rockford, IL, USA). The radioactivity of the sample was measured in counts per minute (cpm) using a MicroBeta ® JET liquid scintillation counter (PerkinElmer, Shelton, CT, USA), and the data were analysed using MicroBeta ® JET workstation software (PerkinElmer). Glucose uptake rate was calculated as cpm/protein concentration and calculated relative to the cpm/protein concentration for 0 µM PA.
RT-PCR ANALYSIS OF MRNA LEVELS
To evaluate the mRNA levels of adiponectin, resistin, AdipoR1 and AdipoR2 in rat tissue, total RNA was extracted and purified with TRIzol ® reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions, from 100 mg of each of the rat livers, kidneys, hearts, adipose tissue and skeletal muscle. Total mRNA was also extracted similarly from HepG2 cells (cultured as described above). RNA (2 µg) was reverse-transcribed using a cDNA synthesis kit (SuperScript ® III RT; Invitrogen), according to the manufacturer's instructions, and PCR was carried out with 1 µg cDNA using a PCR kit and Taq polymerase (Takara Bio Inc., Shiga, Japan) in a GeneAmp ® PCR 2700 thermal cycler (Applied Biosystems, Foster City, USA). The primers, shown in Table 1 , were synthesized by SBS Genetech Co. Ltd, Beijing, China; β-actin was used as the housekeeping gene. The thermal cycling conditions involved an initial denaturation period of 95°C for 5 min, 26 cycles at 94°C for 30 s, 55°C for 30 s and 72°C for 40 s, and a final extension period of 72°C for 10 min. The PCR products were separated on 1% agarose gels, stained with ethidium bromide and visualized under ultraviolet using a Y Gong, J Li, C Li et al. Pioglitazone prophylaxis of insulin resistance bioimaging system (UVP GDS7500 series; UVP LLC, Upland, CA, USA). Data were calculated relative to that of the β-actin housekeeping gene.
WESTERN BLOT ANALYSIS OF PROTEIN LEVELS
To quantify protein levels of adiponectin, resistin, AdipoR1 and AdipoR2, the tissue samples of liver, adipose and muscle from each rat (approximately 0.5 cm 3 for each tissue) and the HepG2 cells (cultured as described above) were lysed by sonication in 100 µl ice-cold lysis buffer (containing Tris-HCl, pH 7.5, 150 mM saline, 1 mM ethylenediaminetetra-acetic acid, 2 mM dithiothreitol, 2 mM phenylmethylsulphonyl fluoride and 1% Triton X-100). The lysates were centrifuged at 13 400 g for 10 min at 4°C and stored at -70°C until analysis. The protein concentration of each sample was determined by BCA protein assay (Thermo Fisher Scientific) and equal amounts of protein were separated by sodium dodecylsulphate polyacrylamide gel electrophoresis (10% gels for adiponectin, AdipoR1 and AdipoR2, and 16% gels for resistin). 
STATISTICAL ANALYSES
The mean ± SD of the data were calculated and statistical analyses were carried out using the SPSS ® software package, version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A paired t-test was used to assess differences between any two groups and a one-way analysis of variance was used to evaluate differences between multiple groups. The Tukey-Kramer least significant difference post hoc test was employed for 
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pairwise comparisons between any two groups. A P-value < 0.05 was considered to be statistically significant.
Results
All rats were similar in body weight, blood glucose, insulin and FFA levels at baseline. There was no difference in the mean weight of food consumed between the groups over the course of the study. At 11 weeks, glucose tolerance and insulin resistance tests showed that plasma glucose levels at 0, 30, 60 and 120 min ( Fig. 1A and 1B , respectively) and the AUCs (glucose-time curve) after glycaemic load or insulin injection were significantly higher in the IR group compared with the control and P groups ( Table 2 ; P < 0.01 for both comparisons). At animal sacrifice at week 12, weight, right ventricle blood levels of FBG, FFA and FINS, and the HOMA-IR value of rats in the IR group were increased significantly compared with controls (P < 0.01, Table 2 ). This confirmed that the high-fat diet had induced insulin resistance in this rat model. The FINS level and HOMA-IR in rats of the P group were significantly improved (P < 0.01, Table  2 ) despite the greater body weight of the rats.
The heart (myocardium), liver, kidney, skeletal muscle, testis and adipose tissue of the rats all showed the presence of AdipoR1 mRNA while AdipoR2 mRNA was present at a high level only in the liver, with lower levels observed in the kidney and skeletal muscle ( Fig. 2A) . Thus, mRNA and protein levels of adiponectin, resistin and AdipoR1 were evaluated in adipose tissue, and the mRNA and protein levels of both AdipoR1 and 2 were evaluated in liver and skeletal muscle (Fig. 2B, 2C) .
In adipose tissue, adiponectin and resistin protein decreased significantly in the IR group versus the N group (P < 0.01 and P < 0.05, respectively; Fig 2C) and, in the P group compared with IR group, only adiponectin showed a significant increase (P < 0.05). AdipoR1 protein also tended to decrease in the IR group and increase in the P group but these differences were not statistically significant. In the liver, AdipoR2 protein in the IR group decreased significantly compared with the N group (P < 0.01), and FIGURE 1: (A) Glucose tolerance test results at week 11 at 0, 30, 60 and 120 min after administration of 2 g/kg body weight glucose intragastrically and (B) insulin resistance test results at week 11 + 3 days at 0, 30, 60 and 120 min after administration of 0.4 IU/kg body weight insulin subcutaneously for male Wistar rats after receiving a normal diet (N group), a high-fat insulin resistance-inducing diet (IR group), or an IR diet plus 10 mg/kg body weight per day pioglitazone orally (P group). *P < 0.05, **P < 0.01 for the IR group versus the N group; ## P < 0.01 for the P group versus the IR group 
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significantly increased in the P group versus the IR group (P < 0.05). There was no statistically significant difference between the groups in AdipoR1 protein in liver tissue although, as in adipose tissue, there was some indication of a slight decrease in the IR group and a slight increase in the P group. In skeletal muscle, the changes in AdipoR1 and 2 protein levels showed similar tendencies to those liver, but there was no statistically significant difference between the groups. The mRNA levels for each tissue reflected changes in protein levels (quantitative data not shown).
Studies on HepG2 cells showed that cell survival decreased as PA concentration increased, being significantly different from 0 µM PA at 200 µM (P < 0.05) and 400 µM (P < 0.01) (Fig. 3A) . When PA was ≥ 200 µM, Western blot analysis showed that AdipoR2 protein also decreased significantly at PA ≥ 200 µM compared with 0 µM PA (P < 0.01), but this was ameliorated with 10 µM pioglitazone (P < 0.05 and P < 0.01 for PA concentrations of 200 and 400 µM, respectively; Fig. 3B ). No significant differences were detected in AdipoR1 levels between any of the groups (data not shown).
The study on glucose uptake in HepG2 cells showed that, at a PA concentration of ≥ 200 µM, glucose uptake decreased significantly (P < 0.01) compared with that at 0 µM PA, and this decrease could be partly reversed by pioglitazone (P < 0.05) (Fig. 3C) . Blocking the production of AdipoR2 by siRNA significantly decreased glucose uptake independently of PA or pioglitazone (P < 0.01) (Fig. 3C ).
Discussion
The present study showed that adiposity and insulin resistance appeared in Wistar rats after eating a high-fat diet for 11 weeks, while the prophylactic administration of Areas under the curves (AUC) of glucose tolerance and insulin resistance were tested at week 11 and week 11 + 3 days, respectively. (C) Quantification of the Western blot analyses showing adiponectin, resistin and AdipoR1 protein levels in adipose tissue, and AdipoR1 and 2 protein levels in liver and skeletal muscle tissues from the three groups of rats (mean ± SD relative to β-actin; *P < 0.05, **P < 0.01 for the IR and P groups versus the N group; # P < 0.05 for the P group versus the IR group) pioglitazone with the high-fat diet significantly decreased insulin levels and insulin resistance, without any change in body weight. In addition, FBG and FFA were also reduced following administration of pioglitazone. Thus, prophylactic treatment with pioglitazone in rats fed the high-fat diet reversed the insulin resistance observed in the IR group and exerted an insulinsensitizing effect independent of body weight. Evaluation of lipogenic hormones in the rats showed that adiponectin and resistin in adipose tissue had a positive relationship with insulin sensitivity. Thus, adipocyte dysfunction was found to be closely related to insulin resistance and pioglitazone protection, in which both adiponectin and resistin play a role. These data are in accordance with previous studies. 10,20 -22 Adipose tissue, skeletal muscle and the liver are major target organs of insulin that regulate insulin sensitivity. Li et al. 23 studied biopsies of subcutaneous fat and quadriceps muscle in 14 patients with type 2 diabetes mellitus after treatment with 45 mg pioglitazone or placebo for 21 days and found that AdipoR levels did not change in muscle or adipose tissue. TZDs improve insulin sensitivity by regulating liver enzyme activity involved in lipid metabolism without altering skeletal muscle glycogen synthase. 24 Some authors have suggested that the liver is the key organ that regulates the plasma lipid profile and insulin sensitivity. 16, 20, 23, 25, 26 The present study investigated the involvement of several organs and showed that, with changes in insulin sensitivity, AdipoR2 protein levels changed significantly in the liver rather than in skeletal muscle or adipose tissue.
To study the effects of pioglitazone on mRNA and protein levels of AdipoRs and glucose uptake during high fat induced insulin resistance, HepG2 cells were cultured with various concentrations of PA in the presence or absence of 10 µM pioglitazone. Glucose uptake by the HepG2 cells decreased in parallel with reducing AdipoR2 mRNA and protein levels, and that pioglitazone could increase glucose uptake and the levels of AdipoR2 mRNA and protein. Blocking AdipoR2 production by siRNA caused a significant decrease in glucose uptake by the HepG2 cells that was independent of PA or pioglitazone. Thus, we suggest that the increase of glucose uptake mediated by AdipoR2 in the liver is one of the most important mechanisms of pioglitazone insulin sensitization in high-fat diet-induced insulin resistance.
The relationship between skeletal muscle AdipoRs and insulin resistance is still unclear. Expression levels of AdipoRs were found to be decreased significantly in the skeletal muscle of obese mouse models 27 and also in skeletal muscle of Mexican Americans and African Americans with diabetes, but not in Caucasians with diabetes. 28 -30 Physical training for 4 weeks increased AdipoR expression in skeletal muscle, while a low-fat diet did not. 31 Further studies are required to investigate whether the regulation of insulin resistance in skeletal muscle is similar to that in liver and whether TZDs or lipogenic hormones regulate skeletal muscle directly. 21 The AdipoR2 has been reported to have a medium binding affinity for either spherical or whole-length adiponectin, while AdipoR1 is a high affinity receptor for spherical adiponectin only. 32 Thus, a slight change in AdipoR1 may result in significant changes in insulin sensitivity. The trend in AdipoR1 levels was similar to that of AdipoR2 in the present study, but no significant difference was found. It is still possible that AdipoR1 plays a role in the induction of insulin resistance by a high-fat diet and the subsequent reversal in insulin sensitivity by pioglitazone. 26, 33 In addition, the liver is a key organ associated with glucose metabolism and lipid metabolism. 12, 24 Adiponectin has also been linked to the regulation of lipid metabolism. 10, 15 Thus, future studies will involve investigation of the involvement of adiponectin in the relationship between lipid oxidation and insulin resistance, and the accompanying mechanism of AdipoRs stimulation.
In conclusion, adipocyte dysfunction (especially the reduction in adiponectin and resistin) plays an important role in high-fat
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• Revised accepted 27 June 2012 Copyright © 2012 Field House Publishing LLP diet-induced insulin resistance. Pioglitazone was able to prevent insulin resistance and adipose endocrine dysfunction in rats. Adiponectin is a key adipokine in the mechanism by which TZDs prevent insulin resistance. The regulation of liver AdipoR2 in the glucose uptake mechanism of cells is one of the important ways that pioglitazone improves insulin sensitivity independent of the blood lipid level. The AdipoR receptor family may, therefore, play a role in preventing insulin resistance. Further study of AdipoRs will help to increase understanding of adiponectin, its molecular mechanism, and its relationship to disease conditions. Further investigation of AdipoR1 and AdipoR2 may provide further understanding of the pathology of diabetes and could result in new treatments for patients with diabetes.
